Evaluation of the profile of inflammatory cytokines, through immunohistochemistry, in the skin of patients with allergic contact dermatitis to nickel in the acute and chronic phases

Imagem de Miniatura
Arquivos
art_SILVESTRE_Evaluation_of_the_profile_of_inflammatory_cytokines_through_2018.PDF (1.38 MB)
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2018
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASILEIRA DERMATOLOGIA
Autores
SILVESTRE, Marilene Chaves
Citação
ANAIS BRASILEIROS DE DERMATOLOGIA, v.93, n.6, p.829-835, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Allergic contact dermatitis to ion nickel (Ni+2) is an inflammatory dermatosis, common in industrialized countries. It involves the activation of nickel-specific T-cells, followed by proliferation and induction of a mixed profile of both proinflammatory and regulatory cytokines, suggesting that several T-cell subtypes (helper - Th and cytotoxic - Tc) are involved. A broader understanding of the cytokine profile may lead to new therapeutic approaches. OBJECTIVES: This study aimed to analyze the cytokines TNF-alpha, INIF-gamma, IL-2, IL-4, IL-10, IL-13, IL-17 and IL-23 using the inununohistochemistry technique in order to try to identify their prevalence in chronic and acute eczema of patients with allergic contact dermatitis to Ni+2. METHODS: We performed an immunohistochemical study for eight cytokines in 20 patients with Ni+2 allergic contact dermatitis, biopsied at the site of chronic eczema, triggered by the patient's daily contact with Ni+2, and at the site of acute eczema caused by nickel sulfate, 48 hours after applying the contact test. RESULTS: The stained samples showed positive results for the eight cytokines studied. TNF-alpha, IFN-gamma, IL-4, IL-13 and IL-17 had a higher prevalence in chronic eczema, IL-2 and IL-23 in acute eczema, and IL-10 presented a similar prevalence in both acute and chronic eczema. However, these prevalences were statistically significant only for IL-4 and IL-13. STUDY LIMITATIONS: Small sample size. CONCLUSIONS: In chronic and acute eczema, we observed the presence of a mixed cytokine profile of the T cell subtypes (Th/Tc), suggesting that the responses are expressed at the same time.
Palavras-chave
Allergy and immunology, Cytokines, Dermatitis, allergic contact, Dermatitis, contact, Immunohistochemistry, Nickel
URI
https://observatorio.fm.usp.br/handle/OPI/29902
Referências
  1. Abbas AK, 2008, IMUNOLOGIA CELULAR M
  2. Ashrin MN, 2014, J IMMUNOL, V192, P4025, DOI 10.4049/jimmunol.1300276
  3. Bai S, 2016, MOL MED REP, V14, P671, DOI 10.3892/mmr.2016.5299
  4. Bonefeld CM, 2016, IMMUNOL LETT, V179, P25, DOI 10.1016/j.imlet.2016.01.005
  5. Bordignon V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-19
  6. Borg L, 2000, ARCH DERMATOL RES, V292, P285, DOI 10.1007/s004030000129
  7. Carlsen BC, 2008, CONTACT DERMATITIS, V58, P1
  8. CARVALHO A. R., 2016, THESIS
  9. Conover W. J., 1998, PRACTICAL NONPARAMET
  10. Dittmar D, 2017, CONTACT DERMATITIS, V76, P257, DOI 10.1111/cod.12769
  11. Dolch A, 2017, EXP DERMATOL, V26, P449, DOI 10.1111/exd.13237
  12. Duarte Ida, 2002, Am J Contact Dermat, V13, P125
  13. Fallahi P, 2016, CLIN TER, V167, P112, DOI 10.7417/CT.2016.1953
  14. Falsafi-Amin H, 2000, INT ARCH ALLERGY IMM, V123, P170, DOI 10.1159/000024437
  15. Falsafi-Amin H, 2008, IMMUNOPHARM IMMUNOT, V30, P227, DOI 10.1080/08923970801948960
  16. Gimenez-Rivera VA, 2016, J IMMUNOL, V197, P4240, DOI 10.4049/jimmunol.1600236
  17. Hennino Ana, 2005, An. Bras. Dermatol., V80, P335, DOI 10.1590/S0365-05962005000400003
  18. Heo WI, 2015, CLIN EXP DERMATOL, V40, P665, DOI 10.1111/ced.12567
  19. Hofmann MA, 2016, CURR OPIN ALLERGY CL, V16, P451, DOI 10.1097/ACI.0000000000000310
  20. Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284
  21. Jakobson E, 2002, BRIT J DERMATOL, V147, P442, DOI 10.1046/j.1365-2133.2002.04850.x
  22. Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150
  23. Kim HS, 2016, BMB REP, V49, P293, DOI 10.5483/BMBRep.2016.49.5.023
  24. Kimber I, 2002, INT IMMUNOPHARMACOL, V2, P201, DOI 10.1016/S1567-5769(01)00173-4
  25. Kimber I, 2012, CONTACT DERMATITIS, V67, P179, DOI 10.1111/j.1600-0536.2012.02148.x
  26. Lachapelle JM, 2009, PATCH TESTING PRICK
  27. Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257
  28. Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036
  29. Martins G. A, 2011, ESTATISTICA GERAL AP
  30. Mesquita D, 2010, REV BRAS REUMATOL, V50, P566, DOI 10.1590/S0482-50042010000500008
  31. Nasorri F, 2002, J INVEST DERMATOL, V118, P172, DOI 10.1046/j.0022-202x.2001.01574.x
  32. Natsuaki Y, 2016, MED MOL MORPHOL, V49, P127, DOI 10.1007/s00795-016-0137-4
  33. Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506
  34. Sampaio SAP, 2007, DERMATOLOGICA, P189
  35. Schmidt JD, 2017, CONTACT DERMATITIS, V76, P218, DOI 10.1111/cod.12715
  36. Schmidt M, 2015, J DTSCH DERMATOL GES, V13, P653, DOI 10.1111/ddg.12673
  37. SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591
  38. Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726
  39. Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x
  40. Wang C, 2015, INT IMMUNOPHARMACOL, V24, P325, DOI 10.1016/j.intimp.2014.12.026
  41. Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819
  42. Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557
  43. Yucesoy B, 2016, J IMMUNOTOXICOL, V13, P738, DOI 10.3109/1547691X.2016.1173135

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/56